Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1929 1
1952 1
1953 2
1955 1
1957 1
1958 2
1959 2
1960 3
1961 2
1962 3
1963 2
1964 7
1965 5
1966 7
1967 8
1968 13
1969 24
1970 13
1971 19
1972 19
1973 9
1974 10
1975 12
1976 17
1977 16
1978 16
1979 31
1980 24
1981 25
1982 39
1983 23
1984 31
1985 42
1986 50
1987 36
1988 53
1989 61
1990 42
1991 45
1992 68
1993 37
1994 34
1995 54
1996 40
1997 47
1998 49
1999 45
2000 71
2001 62
2002 75
2003 68
2004 74
2005 100
2006 92
2007 94
2008 78
2009 81
2010 99
2011 87
2012 83
2013 96
2014 123
2015 108
2016 97
2017 110
2018 109
2019 90
2020 114
2021 100
2022 97
2023 75
2024 30

Text availability

Article attribute

Article type

Publication date

Search Results

3,054 results

Results by year

Filters applied: . Clear all
Page 1
Genetic and Immunological Characterization of Brain Metastases from Solid Cancers.
Deguchi S, Akiyama Y, Mitsuya K, Ikeya T, Hozumi C, Iizuka A, Miyata H, Maeda C, Ashizawa T, Nagashima T, Urakami K, Ohshima K, Muramatsu K, Sugino T, Ohde Y, Tsubosa Y, Nishimura S, Yamaguchi K. Deguchi S, et al. Among authors: nishimura s. Anticancer Res. 2024 May;44(5):1983-1994. doi: 10.21873/anticanres.17001. Anticancer Res. 2024. PMID: 38677762
Near-infrared Photoimmunotherapy Targeting Cancer-Associated Fibroblasts in Patient-Derived Xenografts using a Humanized anti-Fibroblast Activation Protein Antibody.
Kobayashi T, Noma K, Nishimura S, Kato T, Nishiwaki N, Ohara T, Kunitomo T, Kawasaki K, Akai M, Komoto S, Kashima H, Kikuchi S, Tazawa H, Shirakawa Y, Choyke PL, Kobayashi H, Fujiwara T. Kobayashi T, et al. Among authors: nishimura s. Mol Cancer Ther. 2024 Apr 18. doi: 10.1158/1535-7163.MCT-23-0527. Online ahead of print. Mol Cancer Ther. 2024. PMID: 38638034
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial.
Pracoń R, Spertus JA, Broderick S, Bangalore S, Rockhold FW, Ruzyllo W, Demchenko E, Nageh T, Grossman GB, Mavromatis K, Manjunath CN, Smanio PEP, Stone GW, Mancini GBJ, Boden WE, Newman JD, Reynolds HR, Hochman JS, Maron DJ; ISCHEMIA Research Group. Pracoń R, et al. Circ Cardiovasc Interv. 2024 Apr 17:e013435. doi: 10.1161/CIRCINTERVENTIONS.123.013435. Online ahead of print. Circ Cardiovasc Interv. 2024. PMID: 38629312
Trans men can achieve adequate muscular development through low-dose testosterone therapy: A long-term study on body composition changes.
Tominaga Y, Kobayashi T, Matsumoto Y, Moriwake T, Oshima Y, Okumura M, Horii S, Sadahira T, Katayama S, Iwata T, Nishimura S, Bekku K, Edamura K, Sugimoto M, Kobayashi Y, Watanabe M, Namba Y, Matsumoto Y, Nakatsuka M, Araki M. Tominaga Y, et al. Among authors: nishimura s. Andrology. 2024 Apr 2. doi: 10.1111/andr.13640. Online ahead of print. Andrology. 2024. PMID: 38563871
Fibroblast activation protein-targeted near-infrared photoimmunotherapy depletes immunosuppressive cancer-associated fibroblasts and remodels local tumor immunity.
Akai M, Noma K, Kato T, Nishimura S, Matsumoto H, Kawasaki K, Kunitomo T, Kobayashi T, Nishiwaki N, Kashima H, Kikuchi S, Ohara T, Tazawa H, Choyke PL, Kobayashi H, Fujiwara T. Akai M, et al. Among authors: nishimura s. Br J Cancer. 2024 Jun;130(10):1647-1658. doi: 10.1038/s41416-024-02639-1. Epub 2024 Mar 30. Br J Cancer. 2024. PMID: 38555315 Free PMC article.
3,054 results